Duke University
Durham, North Carolina, 27710, United States
NCT Number: NCT06805630
This is a research study to measure DNA markers in the urine of patients with upper tract urothelial cancer (UTUC) before surgery and during follow-up visits. Identifying these DNA markers could improve diagnosis before surgery, help assess risk, and predict early recurrence of the cancer. Urine samples will be de-identified and sent to Pangea Laboratory LLC for analysis. The results of this test will be compared to the traditional tests in upper tract urothelial cancer, such as cells in the urine and tissue biopsy.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Durham, North Carolina, 27710, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Urine methylation biomarker test
Time frame: Baseline, 3 months, 6 months
Time frame: Baseline, 3 months, 6 months
Time frame: Baseline, 3 months, 6 months
Duke University
Other
Urine-based Methylation Markers in the Diagnosis and Surveillance of Upper Tract Urothelial Carcinoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05438537
Upper Tract Urothelial Cancer
Hong Kong
View Trial DetailsNCT07673016
Bladder Cancer, Carcinoma
Oceanside, California, United States
View Trial DetailsNCT06822010
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
New Brunswick, New Jersey, United States
View Trial DetailsNCT06987552
Upper Tract Urothelial Cancer
Taipei, Taiwan
View Trial Details